Publication Name	World Journal of Methodology
Manuscript ID	29736
Country	Türkiye

Received	2016-08-26 08:57
Peer-Review Started	2016-08-26 19:42
To Make the First Decision	2016-11-29 16:41
Return for Revision	2016-11-30 12:06
Revised	2016-12-21 05:16
Second Decision	2017-01-09 16:32
Accepted by Journal Editor-in-Chief	2017-01-09 17:53
Accepted by Company Editor-in-Chief	2017-01-18 10:27
Articles in Press	2017-01-18 10:27
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-03-20 09:10
Publish the Manuscript Online	2017-03-24 10:35

ISSN	2222-0682 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Rheumatology
Manuscript Type	Minireviews
Article Title	Laboratory evaluation in rheumatic diseases
Manuscript Source	Invited Manuscript
All Author List	Murat Birtane, Selçuk Yavuz and Nurettin Taştekin
Funding Agency and Grant Number
Corresponding Author	Selçuk Yavuz, MD, Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Trakya University, Balkan Campus, Edirne 22040, Turkey. selcukyavuz@trakya.edu.tr
Key Words	Autoantibodies; Rheumatic diseases; Auto-immune diseases; Laboratory biomarkers; Diagnostic markers
Core Tip	Serological and proteomic biomarkers are useful in confirming clinically suspected preliminary diagnosis, monitoring the treatment response and prognosis of autoimmune diseases. Tests for acute phase proteins, rheumatoid factor, anti-citrullinated peptide antibodies and antinuclear antibodies, may support the diagnoses of rheumatic diseases. But these biomarkers should be used beside a careful anamnesis and detailed physical examination. Improper using of these tests may cause false-positive results and unnecessary harmful treatments. The sensitivity, specificity and likelihood ratios of the test must be known. If the test is highly specific, the diagnosis can be confirmed in case of positivity and if it is highly sensitive, the possible diagnosis can be excluded in case of negativity.
Publish Date	2017-03-24 10:35
Citation	Birtane M, Yavuz S, Taştekin N. Laboratory evaluation in rheumatic diseases. World J Methodol 2017; 7(1): 1-8
URL	http://www.wjgnet.com/2222-0682/full/v7/i1/1.htm
DOI	http://dx.doi.org/10.5662/wjm.v7.i1.1

Full Article (PDF)	WJM-7-1.pdf
Full Article (Word)	WJM-7-1.doc
Manuscript File	29736-Review.docx
Answering Reviewers	29736-Answering reviewers.pdf
Audio Core Tip	29736-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	29736-Conflict-of-interest statement.pdf
Copyright License Agreement	29736-Copyright assignment.pdf
Peer-review Report	29736-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	29736-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	29736-Scientific misconduct check.pdf
Scientific Editor Work List	29736-Scientific editor work list.pdf